encyclopedia of medical concepts
ψ 
ψ 
ψ 

Aclarubicin

More information in Books or onNLM PubMed
Definition: An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.     
Pharmacological Action Antibiotics, Antineoplastic 		Other names Aclacinomycin A; NSC208734; NSC 208734; MA144A1; NSC-208734; Medac Brand of Aclarubicin Hydrochloride; MA 144A1; MA-144A1; Lundbeck Brand of Aclarubicin Hydrochloride; Aclaplastin; Aclacin
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
10-decarboxymethylaclacinomycin T  0   Aclarubicin/*analogs & derivatives. J Biol Chem 2003 Oct 3;278(40):39006-13
15-demethoxyaclacinomycin T  0   Aclarubicin/*analogs & derivatives. J Biol Chem 2003 Oct 3;278(40):39006-13
BHAC-AMP protocol  0   *Antineoplastic Combined Chemotherapy Protocols Cytarabine/analogs & derivatives Prednisolone 6-Mercaptopurine Aclarubicin. Int J Hematol 2001 Jul;74(1):53-7
CAG protocol  0   *Antineoplastic Combined Chemotherapy Protocols Cytarabine Aclarubicin Granulocyte Colony-Stimulating Factor. Int J Hematol 2000 Apr;71(3):238-44
CAOP protocol  0   *Antineoplastic Combined Chemotherapy Protocols Cyclophosphamide Prednisolone Vincristine Aclarubicin. Cancer Genet Cytogenet 1996 Aug;90(1):45-8
11-hydroxyaclacinomycin X  0   Aclarubicin/*analogs & derivatives. J Antibiot (Tokyo) 1996 Apr;49(4):355-60
11-hydroxyaclacinomycin A  0   Aclarubicin/*analogs & derivatives. Antimicrob Agents Chemother 1995 Jul;39(7):1616-20
2-hydroxyaclacinomycin B  85819-82-5   Aclarubicin/*analogs & derivatives. Jpn J Antibiot 1991;44(3):277
BGM 84 protocol  0   *Antineoplastic Combined Chemotherapy Protocols Cytarabine Aclarubicin. Nouv Rev Fr Hematol 1990;32(2):147
ABEP protocol 1  0   *Antineoplastic Combined Chemotherapy Protocols Cytarabine/analogs & derivatives Etoposide Prednisolone Aclarubicin. Cancer Chemother Pharmacol 1989;25(2):135
AB-triple V protocol  0   *Antineoplastic Combined Chemotherapy Protocols Cytarabine/analogs & derivatives Etoposide Vinblastine Vincristine Aclarubicin. Rinsho Ketsueki 1989;30(2):169
AclBEP protocol  0   *Antineoplastic Combined Chemotherapy Protocols Etoposide Prednisolone Aclarubicin. Nippon Gan Chiryo Gakkai Shi 1987;22(6):1176
CAP therapy protocol  0   *Antineoplastic Combined Chemotherapy Protocols Cisplatin Aclarubicin Peplomycin. Nippon Sanka Fujinka Gakkai Zasshi 1986;38(11):2119
BH-AC-AMP protocol  0   *Antineoplastic Combined Chemotherapy Protocols Cytarabine/analogs & derivatives Prednisolone 6-Mercaptopurine Aclarubicin. Rinsho Ketsueki 1984;25(11):1766
6-O-methylaclacinomycin  76264-92-1   Aclarubicin/*analogs & derivatives. J Antibiot (Tokyo):1981;34(7):905
4-O-methylaclacinomycin  76304-86-4 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5-dihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopy  Aclarubicin/*analogs & derivatives. J Antibiot (ToKyo) 1981;34(7):905
aclacinomycins  0   Aclarubicin/*analogs & derivatives.
Pharma Action Adjuvants, Immunologic ; Antibiotics, Antineoplastic 		Antibiot Chemother 23:76;1978; Biochem Biophys Res Commun 82(1):188;1978; Biochemistry 1979;18(18):4024; Cancer Res 38:1782;1978; Cancer Treat Rep 63(5):875;1979; Cancer Treat Rep 63(5):931;1979; Folia Microbiol 23:152;1978; Gann 68(5):685;1977; J Antibiot (Tokyo) 32(1):48;1979; J Antibiot 1979;32(5):472; J Antibiotics 28(10):830;1975; J Antibiotics 31(9):919;1978; Jpn J Antibiot 30 suppl:S-70;1977; Lancet 2(8137):301;1979; Recent Results Canc Res 63:241;1978
2-hydroxyaclacinomycin A  79127-36-9 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,9-tetrahydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyran  Aclarubicin/*analogs & derivatives. J Antibiot (Tokyo) 1981;34(11):1494

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy